Genentech says it can’t keep up with Tamiflu production, and the shortage is reported as a problem. Or is it.
Well, like most crises, it’s not, the benefits are overrated and amount to a reduction in severity or length of the flu at best, and Tamiflu resistance is increasing.
http://www.franchiseherald.com/articles/4616/20140109/tamiflu-flu-medicine-production-issues-delay-childrens-recovery-capsule-form-in-regular-supply.htm